Doctors in the evidence-based medicine world have been researching them for decades, and are optimistic about their ability to act as what are known as signaling molecules, encouraging the body to do things such as regulate blood sugar to help patients with diabetes
The findings indicated that the absolute risk for suicide among broad groups of GLP-1 receptor agonist users are low and any potential risk increase would be small, the researchers wrote
J., and DeFelice, S
Employer Strategies SmithRx Key Takeaways GLP-1 demand has exploded for diabetes/weight loss, creating shortages and huge pharmacy spending that can force employers to raise premiums or cut coverage
PubMed Sikiric, P., Hahm, K.B., Blagaic, A.B., Tvrdeic, A., Pavlov, K.H., Petrovic, A., Kokot, A., Gojkovic, S., Krezic, I., Drmic, D., Rucman, R., & Seiwerth, S